Aigen Investment Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Aigen Investment Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,256	Closed	-$60K	–	1460
2020 Q1	$60K	Buy	+1,256	New	+$58.4K	0.01%	951

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Aigen Investment Management's RARX Position: Q2 2020 in Review

Aigen Investment Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 1,256 shares — an estimated $60K sold.

Aigen Investment Management first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $60K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Aigen Investment Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Aigen Investment Management sold 1,256 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $60K.
Aigen Investment Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Aigen Investment Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $60K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.